Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И.Евдокимова» Минздрава России. 127473, Россия, Москва, ул. Делегатская, д. 20, стр. 1
A.V.Pavlichenko A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation. 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1
Список исп. литературыСкрыть список 1. Крепелин Э. Введение в психиатрическую клинику. Пер. с нем. М.: БИНОМ, 2009. / Krepelin E. Vvedenie v psikhiatricheskuiu kliniku. Per. s nem. M.: BINOM, 2009. [in Russian] 2. МКБ-10: раздел «Психические и поведенческие расстройства». М., 1998. / MKB-10: razdel «Psikhicheskie i povedencheskie rasstroistva». M., 1998. [in Russian] 3. Шнайдер К. Клиническая психопатология. Пер. с нем. Киев: Сфера, 1999. / Shnayder K. Klinicheskaia psikhopatologiia. Per. s nem. Kiev: Sfera, 1999. [in Russian] 4. Bottlender R, Sato T, Jager M et al. Does considering duration of negative symptoms increase their specificity for schizophrenia? Schizophr Res 2003; 60 (2–3): 321–2. 5. Bora E et al. Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond. Schizophr Bull 2010; 36 (1): 36–42. 6. Bowie CR et al. Predicting schizophrenia patients’ real world behavior with specific neuropsychological and functional capacity measures. Biol Psychiatry 2008; 63: 505–11. 7. David AS. Why we need more debate on whether psychotic symptoms lie on a continuum with normality. Psychol Med 2010; 40 (12): 1935–42. 8. Fervaha G. Motivational deficits and cognitive test performance in schizophrenia. JAMA Psychiatry 2014; 71 (9): 1058–65. 9. Gaebel W (ed.) Schizophrenia: Current science and clinical practice. Wiley-Blackwell, 2011. 10. Gaebel W et al. Psychotic disorders in ICD-11. Asian J Psychiatr 2013; 6 (3): 263–5. 11. Gaebel W, Zielasek J. Focus on psychosis. Dialogues Clin Neurosci 2015; 17 (1): 9–18. 12. George B, Klijn A. A modern name for schizophrenia (PSS) would diminish selfstigma. Psychol Med 2013; 43: 1555–7. 13. Henderson S et al. Swan song for schizophrenia? Aust NZ J Psychiatr 2014; 48: 302–5. 14. Hopper K, Harrison G, Janca A (eds). Recovery from schizophrenia: an international perspective. Oxford University Press 2007. 15. Jablensky A. Psychiatric classifications: validity and utility. World Psychiatry 2016; 15 (1): 26–31. 16. Kingdon D et al. Changing name: changing prospects for psychosis. Epidemiol Psychiatr Sci 2013; 22: 297–301. 17. Lasalvia A et al. Should the label "schizophrenia" be abandoned? Schizophr Res 2015; 162 (1–3): 276–84. 18. Linscott RJ, van Os J. Systematic reviews of categorical versus continuum models in psychosis: evidence for discontinuous subpopulations underlying a psychometric continuum. Implications for DSM-V, DSM-VI, and DSM-VII. Annu Rev Clin Psychol 2010; 6: 391–419. 19. Maj M. Critique of the DSM-IV operational diagnostic criteria for schizophrenia. Br J Psychiatry 1998; 172: 458, 460. 20. Maj M. The self and schizophrenia: some open issues. World Psychiatry 2012; 11 (2): 65–6. 21. Maj M. DSM, ICD, RDoC, and psychiatry’s shifting seas. EPA Congress News. 3 March 2014; p. 4. 22. Makinen J et al. Negative symptoms in schizophrenia: a review. Nordic J Psychiatry 2008; 62 (5): 334–41. 23. Moncrieff J et al. Schizophrenia: a critical psychiatry perspective. Curr Opin Psychiatry 2015; 28 (3): 264–8. 24. Murray RM et al. Schizophrenia: from developmental deviance to dopamine dysregulation. Eur Neuropsychopharmacol 2008; 18 (Suppl. 3): S129–34. 25. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005; 19 (Suppl. 1): 1–93. 26. Nordgaard J et al. The diagnostic status of first-rank symptoms. Schizophr Bull 2008; 34 (1): 137–54. 27. Parnas J. The core Gestalt of schizophrenia. World Psychiatry 2012; 11 (2): 67–9. 28. Perälä J et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007; 64 (1): 19–28. 29. Peralta V, Cuesta MJ. Diagnostic significance of Schneider's first-rank symptoms in schizophrenia. Comparative study between schizophrenic and non-schizophrenic psychotic disorders. Br J Psychiatry 1999; 174: 243–8. 30. Pogue-Geile M et al. Negative symptomatology and schizophrenia: a conceptual and empirical review. Int J Mental Health 1988; 16 (4): 3–45. 31. Ramperti N et al. First rank symptoms in first episode psychosis and their relationship to the duration of untreated illness. J Nerv Ment Dis 2010; 198 (11): 820–3. 32. Tandon R. Nosological status and definition of schizophrenia: Some considerations for DSM-V and ICD-11. Asian J Psychiatr 2008; 1 (2): 22–7. 33. Szasz T. Schizophrenia: The Sacred Symbol of Psychiatry. Syracuse, New York: Syracuse University Press, 1988. 34. Snitz B et al. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr Bull 2006; 32 (1): 179–94. 35. van Os J et al. The schizophrenia envirome. Curr Opin Psychiatry 2005; 18 (2): 141–5. 36. van Os J. ‘Salience syndrome’ replaces ‘schizophrenia’ in DSM-V and ICD-11: psychiatry's evidence-based entry into the 21st century? Acta Psychiatr Scand 2009; 120: 363–72. 37. van Os J et al. Psychosis as a transdiagnostic and extended phenotype in the general population. World Psychiatry 2016; 15 (2): 118–24. 38. van Os J et al. "Schizophrenia" does not exist. BMJ 2016; 352